Objectives Programmed cell death-ligand 1 (PD-L1) is expressed on tumor cells (TC) and
tumor-infiltrating immune cells (IC). We conducted a retrospective study to investigate the …

Response evaluation after immunotherapy in NSCLC: Early resp... : Medicine Response
evaluation after immunotherapy in NSCLC: Early response assessment using FDG PET/CT …

AIM To investigate the predictive value of integrated 2-[18 F]-fluoro-2-deoxy-d-glucose (18 F-
FDG) positron-emission tomography/computed tomography (PET/CT) for the prediction of …

Abstract Purpose PD-L1 PET imaging, as a non-invasive procedure, can perform a real-time,
dynamic and quantitative analysis of PD-L1 expression at tumor sites. In this study, we …

Background Programmed death-ligand 1 (PD-L1) status can affect the efficacy of
immunotherapy. Based on the link between PD-L1 expression and metabolism, we …

1114 Objectives: Globally, lung cancer is the number one cause of cancer mortality and has
an estimated incidence of 1.3 million new cases every year. Recently, the rise of …

To examine the association between 18F-fluorodeoxyglucose (18F-FDG) uptake in positron
emission tomography/computed tomography (PET/CT) and the response to anti …

Objectives. Immune checkpoint blockers constitute the first‐line treatment for advanced non‐
small‐cell lung cancer (NSCLC) with≥ 50% PD‐L1 expression. In NSCLC, PD‐L1 positivity …

206 Purpose: Total lesion glycolysis (TLG) and other quantitative parameters derived from
18 F-fludeoxyglucose (FDG) PET/CT have been shown to be prognostic for survival in a …

Background Anti-PD-(L) 1 agents play an important role in the management of NSCLC. PD-
L1 analysis by immunohistochemistry is an important biomarker but displays temporospatial …